Baker Bros. Advisors’s Neurogene NGNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14.8M | Sell |
|
|||||
|
2025
Q1 | $17.4M | Buy |
|
|||||
|
2024
Q4 | $15.4M | Buy |
|
|||||
|
2024
Q3 | $19.1M | Hold |
|
|||||
|
2024
Q2 | $16.6M | Hold |
|
|||||
|
2024
Q1 | $23.2M | Buy |
|
|||||
|
2023
Q4 | $8.79M | Buy |
|
|||||
|
2023
Q3 | $4.82M | Buy |
|
|||||
|
2023
Q2 | $3.17M | Hold |
|
|||||
|
2023
Q1 | $2.68M | Hold |
|
|||||
|
2022
Q4 | $1.95M | Hold |
|
|||||
|
2022
Q3 | $2.45M | Hold |
|
|||||
|
2022
Q2 | $3.94M | Hold |
|
|||||
|
2022
Q1 | $7.18M | Hold |
|
|||||
|
2021
Q4 | $18.4M | Hold |
|
|||||
|
2021
Q3 | $27.6M | Hold |
|
|||||
|
2021
Q2 | $35.3M | Hold |
|
|||||
|
2021
Q1 | $47M | Hold |
|
|||||
|
2020
Q4 | $53.9M | Hold |
|
|||||
|
2020
Q3 | $45.9M | Buy |
|
|||||
|
2020
Q2 | $56.4M | Hold |
|
|||||
|
2020
Q1 | $38.7M | Hold |
|
|||||
|
2019
Q4 | $41.9M | Sell |
|
|||||
|
2019
Q3 | $32.2M | Buy |
|
|||||
|
2019
Q2 | $25.8M | Hold |
|
|||||
|
2019
Q1 | $29.5M | Hold |
|
|||||
|
2018
Q4 | $23.6M | Hold |
|
|||||
|
2018
Q3 | $32M | Hold |
|
|||||
|
2018
Q2 | $29M | Hold |
|
|||||
|
2018
Q1 | $154M | Hold |
|
|||||
|
2017
Q4 | $129M | Hold |
|
|||||
|
2017
Q3 | $155M | Hold |
|
|||||
|
2017
Q2 | $154M | Hold |
|
|||||
|
2017
Q1 | $182M | Buy |
|
|||||
|
2016
Q4 | $174M | Hold |
|
|||||
|
2016
Q3 | $141M | Buy |
|
|||||
|
2016
Q2 | $51.3M | Hold |
|
|||||
|
2016
Q1 | $68.4M | Buy |
|
|||||
|
2015
Q4 | $84.2M | Hold |
|
|||||
|
2015
Q3 | $94.9M | Buy |
|
|||||
|
2015
Q2 | $8.31M | Buy |
|
|||||
|
2015
Q1 | $9.76M | Sell |
|
|||||
|
2014
Q4 | $9.08M | Sell |
|
|||||
|
2014
Q3 | $8.07M | Hold |
|
|||||
|
2014
Q2 | $11.4M | Hold |
|
|||||
|
2014
Q1 | $15.4M | Buy |
|